000 | 01581 a2200481 4500 | ||
---|---|---|---|
005 | 20250515071933.0 | ||
264 | 0 | _c20071019 | |
008 | 200710s 0 0 eng d | ||
022 | _a0306-4522 | ||
024 | 7 |
_a10.1016/j.neuroscience.2007.04.056 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTrabace, L | |
245 | 0 | 0 |
_aSoluble amyloid beta1-42 reduces dopamine levels in rat prefrontal cortex: relationship to nitric oxide. _h[electronic resource] |
260 |
_bNeuroscience _cJul 2007 |
||
300 |
_a652-63 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAmyloid beta-Peptides _xpharmacology |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArginine _xpharmacology |
650 | 0 | 4 |
_aDopamine _xmetabolism |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aIndazoles _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMicrodialysis _xmethods |
650 | 0 | 4 |
_aNitric Oxide _xphysiology |
650 | 0 | 4 |
_aPeptide Fragments _xpharmacology |
650 | 0 | 4 |
_aPrefrontal Cortex _xdrug effects |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aKendrick, K M | |
700 | 1 | _aCastrignanò, S | |
700 | 1 | _aColaianna, M | |
700 | 1 | _aDe Giorgi, A | |
700 | 1 | _aSchiavone, S | |
700 | 1 | _aLanni, C | |
700 | 1 | _aCuomo, V | |
700 | 1 | _aGovoni, S | |
773 | 0 |
_tNeuroscience _gvol. 147 _gno. 3 _gp. 652-63 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuroscience.2007.04.056 _zAvailable from publisher's website |
999 |
_c17098596 _d17098596 |